{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:21:02Z","timestamp":1773760862993,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,16]]},"DOI":"10.1097\/01.npr.0000484319.60683.db","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T11:45:32Z","timestamp":1466423132000},"page":"28-33","source":"Crossref","is-referenced-by-count":8,"title":["Genitourinary syndrome of menopause"],"prefix":"10.1097","volume":"41","author":[{"given":"Katherine","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Deneris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/gme.0b013e318182f84b","article-title":"Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach","volume":"15","author":"Ettinger","year":"2008","journal-title":"Menopause"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s11606-008-0820-9","article-title":"Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study","volume":"23","author":"McCall-Hosenfeld","year":"2008","journal-title":"J Gen Intern Med"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society","volume":"79","author":"Portmam","year":"2014","journal-title":"Maturitas"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00192-014-2464-0","article-title":"Assessment of vaginal atrophy: a review","volume":"26","author":"Weber","year":"2015","journal-title":"Int Urogynecol J"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00006205-199909000-00004","article-title":"Clinical application of the vaginal maturation index","volume":"24","author":"McEndree","year":"1999","journal-title":"Nurse Pract"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"Practice Bulletin No. 141: management of menopausal symptoms.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"9","key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e31828786f8","article-title":"Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States","volume":"121","author":"Brown","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"R11-5-20210130","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"Committee Opinion No. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer.","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1742-1241.2007.01587.x","article-title":"The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer","volume":"61","author":"Fabian","year":"2007","journal-title":"Int J Clin Pract"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jsm.12377","article-title":"The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis","volume":"11","author":"Cui","year":"2014","journal-title":"J Sex Med"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifen effectively treats vulvovagainal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"R17-5-20210130","first-page":"605","article-title":"Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast","volume":"5","author":"Soe","year":"2013","journal-title":"Int J Womens Health"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsbmb.2014.09.003","article-title":"Dehydroepiandrosterone intravaginal administration for the management of postmenopausal vulvovaginal atrophy","volume":"145","author":"Archer","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/13697137.2014.992012","article-title":"Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy","volume":"18","author":"Bouchard","year":"2015","journal-title":"Climacteric"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","article-title":"A practical solution for dyspareunia in breast cancer survivors: a randomized control trial","volume":"33","author":"Goetsch","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000484319.60683.db","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T23:48:32Z","timestamp":1656719312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006205-201607000-00005"}},"subtitle":["A new name for an old condition"],"short-title":[],"issued":{"date-parts":[[2016,7,16]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000484319.60683.db","relation":{},"ISSN":["0361-1817"],"issn-type":[{"value":"0361-1817","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,16]]}}}